Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05910775 · ClinicalTrials.gov registry record · NA
Role Of Non-Specific Effects in The Treatment of Depression With Esketamine
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT05910775 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 1 participants.
The verdict
NCT05910775, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The investigators aim to examine the magnitude of non-specific effects in the treatment of depressive episodes with esketamine, by providing patients in the intervention group with a pretreatment presentation and post-treatment follow up session, to assess whether nonspecific effects can be used effectively to improve the effectiveness of treatment with esketamine.
Interventions
- BEHAVIORAL Pre and Post Treatment Presentations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2024-07-13 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05910775
The ClinicalTrials.gov registry entry for NCT05910775 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pre and Post Treatment Presentations is the first listed.
NCT05910775 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05910775 about?
NCT05910775 is a clinical study titled "Role Of Non-Specific Effects in The Treatment of Depression With Esketamine". The investigators aim to examine the magnitude of non-specific effects in the treatment of depressive episodes with esketamine, by providing patients in the intervention group with a pretreatment presentation and post-treatment follow up session, to assess whether nonspecific effects can be used eff...
What is the current status of trial NCT05910775?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2024-07-13. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT05910775?
The interventions under investigation include: Pre and Post Treatment Presentations (BEHAVIORAL).
Who is sponsoring clinical trial NCT05910775?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.